These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1518724)

  • 21. [Radioiodine therapy in differentiated thyroid gland carcinoma].
    Schicha H; Dietlein M
    Zentralbl Chir; 1997; 122(4):266-73. PubMed ID: 9221637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bone tissue mineral density in patients with thyroid gland cancer on levothyroxine natrium therapy].
    Khmara IM; Tolkachev IuV
    Klin Med (Mosk); 2005; 83(10):61-5. PubMed ID: 16320850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review.
    Luster M; Lippi F; Jarzab B; Perros P; Lassmann M; Reiners C; Pacini F
    Endocr Relat Cancer; 2005 Mar; 12(1):49-64. PubMed ID: 15788638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyroid cancer in infants and adolescents after Chernobyl.
    Reiners C; Demidchik YE; Drozd VM; Biko J
    Minerva Endocrinol; 2008 Dec; 33(4):381-95. PubMed ID: 18923372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioiodine therapy of thyroid autonomy.
    Reiners C; Schneider P
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S471-8. PubMed ID: 12192548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiated thyroid carcinoma (DTC) in the elderly: disease outcome, therapeutic approach, and long-term results in a group of 314 patients.
    Girelli ME; Casara D; Rubello D; Mazzarotto R; Saladini G; Busnardo B
    J Endocrinol Invest; 1999; 22(10 Suppl):45-6. PubMed ID: 10727040
    [No Abstract]   [Full Text] [Related]  

  • 27. Thyroid peroxidase (TPO) as a tumor marker in the follow-up of differentiated thyroid carcinomas with surgical and ablative radioiodine therapy. An assessment after evaluation.
    Franke WG; Zöphel K; Wunderlich G; Kühne A; Schimming C; Kropp J; Bredow J
    Anticancer Res; 1999; 19(4A):2711-6. PubMed ID: 10470226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term follow-up in toxic solitary autonomous thyroid nodules treated with radioactive iodine.
    Huysmans DA; Corstens FH; Kloppenborg PW
    J Nucl Med; 1991 Jan; 32(1):27-30. PubMed ID: 1988632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Metabolic therapy with radioiodine of differentiated thyroid tumor].
    Bestagno M; Campagnari G
    Minerva Med; 1986 Nov; 77(44):2113-6. PubMed ID: 3785727
    [No Abstract]   [Full Text] [Related]  

  • 30. [Diagnosis and therapy of differentiated thyroid cancer].
    Georgi P
    Rontgenblatter; 1989 Jan; 42(1):51-3. PubMed ID: 2919261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iodine 131 ((131)I) as adjuvant therapy of differentiated thyroid cancer.
    Lamonica D
    Surg Oncol Clin N Am; 2004 Jan; 13(1):129-49. PubMed ID: 15062366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved planning of radioiodine therapy for thyroid cancer.
    Medvedec M
    J Nucl Med; 2002 May; 43(5):714; author reply 714. PubMed ID: 11994536
    [No Abstract]   [Full Text] [Related]  

  • 33. "High-dose" radioiodine therapy in advanced differentiated thyroid carcinoma.
    Menzel C; Grünwald F; Schomburg A; Palmedo H; Bender H; Späth G; Biersack HJ
    J Nucl Med; 1996 Sep; 37(9):1496-503. PubMed ID: 8790201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radioiodine therapy a successful tool in treating thyroid cancer. Foreword.
    Bombardieri E; Pacini F
    Q J Nucl Med Mol Imaging; 2009 Oct; 53(5):439. PubMed ID: 20205316
    [No Abstract]   [Full Text] [Related]  

  • 35. Commentary on Willegaignon et al.: outpatient radioiodine therapy for thyroid cancer: a safe nuclear medicine procedure.
    Marcus CS
    Clin Nucl Med; 2011 Jun; 36(6):446. PubMed ID: 21552021
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cytogenetic study of thyroid patients treated with external irradiation or radioiodine].
    Katz N; Esik O; Füzy M; Gundy S
    Orv Hetil; 1998 Jun; 139(25):1521-6. PubMed ID: 9676113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conventional Radioiodine Therapy for Differentiated Thyroid Cancer.
    Ylli D; Van Nostrand D; Wartofsky L
    Endocrinol Metab Clin North Am; 2019 Mar; 48(1):181-197. PubMed ID: 30717901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer].
    Lind P; Igerc I; Kohlfürst S
    Wien Med Wochenschr; 2005 Oct; 155(19-20):429-35. PubMed ID: 16424998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Survival times of patients with thyroid cancer following radioiodine therapy].
    Correns HJ; Buchali K; Donat R; zur Horst-Meyer H; Mitterlechner E
    Radiobiol Radiother (Berl); 1984; 25(3):405-10. PubMed ID: 6473745
    [No Abstract]   [Full Text] [Related]  

  • 40. Quantitative approach to radioiodine ablation of thyroid remnants following surgery for thyroid cancer.
    Hadjieva T
    Radiobiol Radiother (Berl); 1985; 26(6):819-23. PubMed ID: 4095270
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.